Utilisation and Outcomes of Eribulin in Triple-Negative Metastatic Breast Cancer (TN MBC): Real-World Findings

被引：0
|
作者：
Kish, Jonathan K. [1 ]
Mougalian, Sarah S. [2 ]
Copher, Ronda [3 ]
McAllister, Lindsay [1 ]
Wang, Zhixiao [3 ]
Janevski, Mile [4 ]
Broscious, Mary [1 ]
机构：
[1] Cardinal Hlth Specialty Solut, Dublin, OH USA
[2] Yale Sch Med, Yale Canc Ctr, New Haven, CT USA
[3] Eisai Inc, Woodcliff Lake, NJ USA
[4] Eisai Australia, Melbourne, Vic, Australia
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
168
引用
收藏
页码：123 / 123
页数：1
相关论文
共 50 条
  • [21] A real-world study of immune checkpoint inhibitors in advanced triple-negative breast cancer
    Zhao, Weihong
    Zhang, Zheng
    Zhang, Yadi
    Chen, Yimeng
    Zhu, Yimin
    Liu, Chuanling
    Shao, Jiakang
    Zhang, Li
    Liu, Mei
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [22] Metastatic Triple-Negative Breast Cancer
    Zhang, Xiaojie
    Yeung, Kay T.
    CURRENT BREAST CANCER REPORTS, 2023, 15 (03) : 288 - 297
  • [23] Metastatic Triple-Negative Breast Cancer
    Xiaojie Zhang
    Kay T. Yeung
    Current Breast Cancer Reports, 2023, 15 : 288 - 297
  • [24] Correction: A real-world study of the effectiveness and safety of apatinib-based regimens in metastatic triple-negative breast cancer
    Weiwei Huang
    Chenxi Wang
    Yangkun Shen
    Qi Chen
    Zhijian Huang
    Jian Liu
    Xiaoyan Lin
    Lili Wang
    Fan Wu
    Xinhua Chen
    Nani Li
    Yi Hong
    Mulan Chen
    Jieyu Li
    Chuanzhong Huang
    BMC Cancer, 24
  • [25] Assessing Real-World Racial Differences Among Patients With Metastatic Triple-Negative Breast Cancer in US Community Practices
    Tan, Ruoding
    Cassoli, Lourenia
    Yan, Ying
    Shen, Vincent
    Day, Bann-mo
    Mitchell, Edith P.
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [26] Outcome in Patients with Metastatic Breast Cancer Treated with Eribulin: A Real-world Cohort
    Rush, H.
    Khan, M.
    Li, S.
    Agorastos, A.
    Kristeleit, H.
    CLINICAL ONCOLOGY, 2018, 30 (06) : E46 - E46
  • [27] Real world study of sacituzumab govitecan in metastatic triple-negative breast cancer in the United Kingdom
    Hanna, Daire
    Merrick, Sophie
    Ghose, Aruni
    Devlin, Michael John
    Yang, Dorothy D.
    Phillips, Edward
    Okines, Alicia
    Chopra, Neha
    Papadimatraki, Elisavet
    Ross, Kirsty
    Macpherson, Iain
    Boh, Zhuang Y.
    Michie, Caroline O.
    Swampillai, Angela
    Gupta, Sunnia
    Robinson, Tim
    Germain, Lewis
    Twelves, Chris
    Atkinson, Charlotte
    Konstantis, Apostolos
    Riddle, Pippa
    Cresti, Nicola
    Naik, Jay D.
    Borley, Annabel
    Guppy, Amy
    Schmid, Peter
    Phillips, Melissa
    BRITISH JOURNAL OF CANCER, 2024, 130 (12) : 1916 - 1920
  • [28] Safety and efficacy of eribulin for "real-world" older patients with metastatic breast cancer
    de Nonneville, Alexandre
    Sabatier, Renaud
    Goncalves, Anthony
    Extra, Jean-Marc
    Tarpin, Carole
    Launay, Simon
    Tassy, Louis
    Viens, Patrice
    Rousseau, Frederique
    JOURNAL OF GERIATRIC ONCOLOGY, 2018, 9 (03) : 281 - 283
  • [29] Real-world analysis of eribulin in metastatic breast cancer (MBC): An assessment of time to treatment failure (TTF) in a community oncology setting
    Dranitsaris, George
    Tripathy, Debu
    Beegle, Nancy L.
    Kalberer, Traci L.
    Cox, John David
    Faria, Claudio
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (26)
  • [30] Outcomes in patients (pts) with metastatic triple-negative breast cancer (mTNBC) treated in second line (2L) in the US real-world setting
    Luhn, P.
    O'Hear, C.
    Ton, T. G.
    Hsieh, A.
    Yi, J.
    Chang, C-W
    Funke, R.
    Kurian, A.
    CANCER RESEARCH, 2019, 79 (04)
12345